JPMorgan raises BioMarin Pharmaceutical target price to $87 from $86
BMRN•JPMorgan raised its target price for BioMarin Pharmaceutical to $87 from $86.
Related News
KKR: Piper Sandler cuts target price to $121 from $128
KKR•
Zealand Pharma reports ZP9830 well tolerated in Phase 1 multiple-dose trial
ZEAL•
BRHC Holdings cuts target price to $32 from $36
BEPC•
Northrim Bancorp target price cut to $29 from $30
NRIM•
Illumina Inc: Canaccord Genuity raises target price to $300 from $205
ILMN•